source
- Novartis and Novo Nordisk trials lower biomarkers but fail to cut heart events, prompting preventive cardiology rethinkThe article discusses two recent Phase 3 trials that achieved their biological goals but did not improve clinical outcomes. Novartis reported that pelacarsen in the Lp(a) HORIZON study successfull…
- Heidi Overton, Trump’s FDA nominee, to appear before Senate committee for confirmation hearingHeidi Overton, a 37‑year‑old preventive‑medicine physician, is the Trump administration’s pick to lead the Food and Drug Administration and will face a Senate committee this morning. Lawmakers hav…